APA (7th ed.) Citation

Domingos-Pereira, S., Cesson, V., Chevalier, M. F., Derré, L., Jichlinski, P., & Nardelli-Haefliger, D. (2017). Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer. OncoImmunology, 6(1), 1. https://doi.org/10.1080/2162402X.2016.1265720

Chicago Style (17th ed.) Citation

Domingos-Pereira, Sonia, Valérie Cesson, Mathieu F. Chevalier, Laurent Derré, Patrice Jichlinski, and Denise Nardelli-Haefliger. "Preclinical Efficacy and Safety of the Ty21a Vaccine Strain for Intravesical Immunotherapy of Non-muscle-invasive Bladder Cancer." OncoImmunology 6, no. 1 (2017): 1. https://doi.org/10.1080/2162402X.2016.1265720.

MLA (9th ed.) Citation

Domingos-Pereira, Sonia, et al. "Preclinical Efficacy and Safety of the Ty21a Vaccine Strain for Intravesical Immunotherapy of Non-muscle-invasive Bladder Cancer." OncoImmunology, vol. 6, no. 1, 2017, p. 1, https://doi.org/10.1080/2162402X.2016.1265720.